{'fraction_non_alphanumeric': 0.03371970495258166, 'fraction_numerical': 0.0, 'mean_word_length': 6.251908396946565, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Management of pulmonary hypertension: basic treatment

The management of patients with pulmonary arterial hypertension (PAH) comprises a complex strategy that includes targeted PAH therapies, but also basic treatment of the disease. This chapter focuses on the latter, which may be subdivided into general measures (physical activity/supervised rehabilitation, pregnancy, birth control/postmenopausal hormonal therapy, elective surgery, infection prevention, psychosocial support, genetic counselling, and travel), and supportive care (anticoagulation, diuretics, oxygen, cardiovascular drugs, iron deficiency, and rhythm control). These additional treatments are an integral part of patient management which help to improve morbidity and mortality in patients with PAH. Treatment decisions are based on the initial evaluation of severity and risk assessment, the presence of co-morbidities, the response to treatment, and the course of the disease.